BRPI0817053A2 - Orlistat Pharmaceutical Formulations - Google Patents

Orlistat Pharmaceutical Formulations

Info

Publication number: BRPI0817053A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical formulations; orlistat; orlistat pharmaceutical; formulations; pharmaceutical
Prior art date: 2007-09-17

Application number

Other languages

Portuguese (pt)

Inventor

Soma Sekhar Kothamasu

Arti Sah

Uma Sowjanya Asapu

Maheswara Reddy Arumalla

Original Assignee

Reddys Lab Ltd Dr

Reddys Lab Inc Dr

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-17

Filing date

2008-09-17

Publication date

2015-03-24

2008-09-17 Application filed by Reddys Lab Ltd Dr, Reddys Lab Inc Dr filed Critical Reddys Lab Ltd Dr

2015-03-24 Publication of BRPI0817053A2 publication Critical patent/BRPI0817053A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0817053 2007-09-17 2008-09-17 Orlistat Pharmaceutical Formulations BRPI0817053A2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN2070CH2007		2007-09-17
US2545608P	2008-02-01	2008-02-01
PCT/US2008/076641 WO2009039157A2 (en)	2007-09-17	2008-09-17	Orlistat pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
BRPI0817053A2 true BRPI0817053A2 (en)	2015-03-24

Family

ID=40468740

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0817053 BRPI0817053A2 (en)	2007-09-17	2008-09-17	Orlistat Pharmaceutical Formulations

Country Status (4)

Country	Link
US (1)	US20100196464A1 (en)
BR (1)	BRPI0817053A2 (en)
EA (1)	EA201070378A1 (en)
WO (1)	WO2009039157A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009044380A2 (en) *	2007-10-05	2009-04-09	Ranbaxy Laboratories Limited	Formulations containing orlistat particles having controlled particle size
PL216542B1 (en) *	2008-03-20	2014-04-30	Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna	Production method of a stable Orlistat composition in form of encapsulated powder
BRPI0901602B8 (en) *	2009-04-03	2021-05-25	Ems S/A	pharmaceutical formulation
WO2012082083A1 (en) *	2010-12-15	2012-06-21	Les Laboratoires Medis Sa	Pharmaceutical formulation containing tetrahydrolipstatin as an active ingredient
MX336980B (en) *	2010-12-21	2016-02-09	Senosiain S A De C V Lab	Combination and composition for treating obesity.
CN103222964B (en) *	2013-01-29	2014-10-08	青岛大学	Orlistat oral preparation and preparation method thereof
KR101937069B1 (en)	2014-12-17	2019-04-03	엠프로스 파마 악티에볼라그	Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
CN111110694B (en) *	2019-12-04	2023-01-24	中山万远新药研发有限公司	Composition containing orlistat and alginic acid or derivatives thereof and application thereof
WO2021236581A1 (en) *	2020-05-18	2021-11-25	Board Of Regents, The University Of Texas System	Granules for 3d printing technology

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1247547A (en) *	1983-06-22	1988-12-28	Paul Hadvary	Leucine derivatives
US6004996A (en) *	1997-02-05	1999-12-21	Hoffman-La Roche Inc.	Tetrahydrolipstatin containing compositions
DE60000796T2 (en) *	1999-01-29	2003-09-18	F. Hoffmann-La Roche Ag, Basel	Purification of lipstatin
US6730319B2 (en) *	2001-06-06	2004-05-04	Hoffmann-La Roche Inc.	Pharmaceutical compositions having depressed melting points
AU2002362061A1 (en) *	2001-12-04	2003-06-17	Biogal Gyogyszergyar Rt	Preparation of orlistat and orlistat crystalline forms
US7241557B2 (en) *	2004-07-30	2007-07-10	Agfa Graphics Nv	Photopolymerizable composition
EP1791520A2 (en) *	2004-08-19	2007-06-06	Alza Corporation	Controlled release nanoparticle active agent formulation dosage forms and methods
WO2006090350A1 (en) *	2005-02-28	2006-08-31	Ranbaxy Laboratories Limited	A method for sieving pharmaceutical substances
US20060246141A1 (en) *	2005-04-12	2006-11-02	Elan Pharma International, Limited	Nanoparticulate lipase inhibitor formulations
US20080021092A1 (en) *	2006-01-06	2008-01-24	Deepak Murpani	Stable pharmaceutical compositions of orlistat

2008
- 2008-09-17 US US12/678,552 patent/US20100196464A1/en not_active Abandoned
- 2008-09-17 EA EA201070378A patent/EA201070378A1/en unknown
- 2008-09-17 WO PCT/US2008/076641 patent/WO2009039157A2/en not_active Ceased
- 2008-09-17 BR BRPI0817053 patent/BRPI0817053A2/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2009039157A2 (en)	2009-03-26
WO2009039157A3 (en)	2009-05-07
EA201070378A1 (en)	2010-08-30
US20100196464A1 (en)	2010-08-05

Publication	Publication Date	Title
BRPI0820381A2 (en)	2015-05-19	Pharmaceutical Formulations
LTPA2018005I1 (en)	2018-02-12	Pharmaceutical composition
NO20075628L (en)	2007-11-05	Pharmaceutical formulations
BRPI0814252A2 (en)	2015-04-14	Antibody Formulations
PT2889310T (en)	2018-03-26	ANTIBODY FORMULATIONS
DK3492069T3 (en)	2022-03-14	PHARMACEUTICAL COMPOSITIONS INCLUDING IRON-OXY-HYDROXIDE
DK2073795T3 (en)	2014-02-03	Abuse-safe drug formulation
DK2066354T3 (en)	2013-05-27	Norovirus vaccine formulations
BRPI0721651A2 (en)	2014-04-01	PHARMACEUTICAL COMPOSITION
DK2079456T3 (en)	2013-03-18	PHARMACEUTICAL CYCLOSPORINE COMPOSITIONS
BRPI0814188A2 (en)	2014-10-14	FORMULATIONS
DK3061445T3 (en)	2023-09-11	Highly concentrated pharmaceutical formulations
BRPI0920521A2 (en)	2018-01-16	pharmaceutical combination
DK2068886T3 (en)	2013-11-18	Lipid-containing preparations
ITBO20050123A1 (en)	2005-06-06	GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA
BRPI0715712A2 (en)	2014-06-24	PHARMACEUTICAL COMPOSITION
DK2120884T3 (en)	2011-02-07	Pharmaceutical composition
DK2966175T3 (en)	2019-07-01	PHARMACEUTICAL COMPOSITIONS CONTAINING CORTEXOLON-17-ALPHA-PROPIONATE
BRPI0921654A2 (en)	2016-02-10	pharmaceutical formulation
PT2209464E (en)	2014-09-05	ANTIMALARIC PHARMACEUTICAL COMPOSITION
BRPI0817053A2 (en)	2015-03-24	Orlistat Pharmaceutical Formulations
BRPI0809441A2 (en)	2015-06-23	Pharmaceutical Formulations of Ghrh Molecules
BRPI0820198A2 (en)	2019-09-24	pharmaceutical compositions
DK2182988T3 (en)	2014-05-26	RADIO PHARMACEUTICAL PREPARATION
BRPI0809653A2 (en)	2014-10-07	MANOPROTEIN NET FORMULATIONS

Legal Events

Date	Code	Title	Description
2015-06-09	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2015-09-08	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]